Standard Operating Procedure to Optimize Resazurin-Based Viability Assays
Biosensors · 26.03.2024 · 14 (4) · 156
DOI: 10.3390/bios14040156 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 26.03.2024. Verfasst von Jessica Petiti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Advanced Materials Metrology and Life Sciences, Istituto Nazionale di Ricerca Metrologica (INRIM), 10135 Turin, Italy. Hauptthemen laut MEDLINE: Xanthenes, Oxazines, Cell Survival. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LifeSaver Project (European Union's Horizon 2020 Research and Innovation Programme), European Union’s Horizon 2020 Research and Innovation Programme.
Abstract (Originalsprache)
The resazurin assay, also known as the Alamar Blue assay, stands as a cornerstone technique in cell biology, microbiology, and drug development. It assesses the viability of cells through the conversion of resazurin into highly fluorescent resorufin. The resulting fluorescence intensity provides a reliable estimate of viable cell numbers. Cytotoxicity assays, such as the resazurin-based method, play a crucial role in the screening of potential drug candidates and in the assessment of pharmaceutical and chemical toxicity. In recent years, inconsistencies have arisen in pharmacogenomic studies, often due to poorly optimized laboratory protocols. These inconsistencies hinder progress in understanding how substances affect cell health, leading to unreliable findings. Thus, the need for standardized and rigorously optimized protocols is evident to ensure consistent and accurate results in cytotoxicity studies. This manuscript describes a standardized procedure for optimizing resazurin-based viability assays to improve the reliability of cytotoxicity data. This optimization approach focuses on critical experimental parameters and data quality, aiming to achieve a level of measurement imprecision of less than 20%. In conclusion, to address the critical issues of reproducibility and reliability, protocol standardization, such as the one described in this manuscript, can greatly enhance the credibility of cytotoxicity studies, ultimately advancing drug safety assessments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Advanced Materials Metrology and Life Sciences, Istituto Nazionale di Ricerca Metrologica (INRIM), 10135 Turin, Italy.
ORCID-Profile: Jessica Petiti, Carla Divieto
Förderung
- LifeSaver Project (European Union's Horizon 2020 Research and Innovation Programme)
- European Union’s Horizon 2020 Research and Innovation Programme
Zitieren
APA
Petiti, J., Revel, L., & Divieto, C. (2024). Standard Operating Procedure to Optimize Resazurin-Based Viability Assays. Biosensors, 14(4), 156. https://doi.org/10.3390/bios14040156
Vancouver
Petiti J, Revel L, Divieto C. Standard Operating Procedure to Optimize Resazurin-Based Viability Assays. Biosensors. 2024;14(4):156. doi:10.3390/bios14040156
BibTeX
@article{Petiti2024,
author = {Petiti, Jessica and Revel, Laura and Divieto, Carla},
title = {Standard Operating Procedure to Optimize Resazurin-Based Viability Assays},
journal = {Biosensors},
year = {2024},
volume = {14},
number = {4},
pages = {156},
doi = {10.3390/bios14040156}
}
EUVIMED